Effects of telmisartan and losartan treatments on bone turnover markers in patients with newly diagnosed stage I hypertension.

Berna İmge AydoğanEmrah ErarslanUğur ÜnlütürkSevim Güllü

Published in: Journal of the renin-angiotensin-aldosterone system : JRAAS (2020)

Neither telmisartan, despite its partial peroxisome proliferator-activated receptor-γ agonistic effect, nor losartan treatment had significant effects on bone turnover markers in newly diagnosed stage I hypertensive patients.

Keyphrases

newly diagnosed
bone mineral density
hypertensive patients
blood pressure
postmenopausal women
body composition
angiotensin ii
soft tissue
bone loss
bone regeneration
binding protein